Sign in or 

Sanofi-Aventis Circles Genzyme
Jul 23 2010, 10:45 PM EDT
(view original item)
Sanofi-Aventis has made an informal acquisition approach to biotechnology drug maker Genzyme, which has a market value of about $14 billion. |
|